Search

Your search keyword '"Kazancıoğlu, Rümeyza"' showing total 166 results
Start Over Author "Kazancıoğlu, Rümeyza"
166 results on '"Kazancıoğlu, Rümeyza"'

2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

Author

Stevens, Paul E., Ahmed, Sofia B., Carrero, Juan Jesus, Foster, Bethany, Francis, Anna, Hall, Rasheeda K., Herrington, Will G., Hill, Guy, Inker, Lesley A., Kazancıoğlu, Rümeyza, Lamb, Edmund, Lin, Peter, Madero, Magdalena, McIntyre, Natasha, Morrow, Kelly, Roberts, Glenda, Sabanayagam, Dharshana, Schaeffner, Elke, Shlipak, Michael, Shroff, Rukshana, Tangri, Navdeep, Thanachayanont, Teerawat, Ulasi, Ifeoma, Wong, Germaine, Yang, Chih-Wei, Zhang, Luxia, and Levin, Adeera

Published
2024
Full Text
View/download PDF

3. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns

Author

Levin, Adeera, Ahmed, Sofia B., Carrero, Juan Jesus, Foster, Bethany, Francis, Anna, Hall, Rasheeda K., Herrington, Will G., Hill, Guy, Inker, Lesley A., Kazancıoğlu, Rümeyza, Lamb, Edmund, Lin, Peter, Madero, Magdalena, McIntyre, Natasha, Morrow, Kelly, Roberts, Glenda, Sabanayagam, Dharshana, Schaeffner, Elke, Shlipak, Michael, Shroff, Rukshana, Tangri, Navdeep, Thanachayanont, Teerawat, Ulasi, Ifeoma, Wong, Germaine, Yang, Chih-Wei, Zhang, Luxia, Robinson, Karen A., Wilson, Lisa, Wilson, Renee F., Kasiske, Bertram L., Cheung, Michael, Earley, Amy, and Stevens, Paul E.

Published
2024
Full Text
View/download PDF

4. Conservative kidney management and kidney supportive care: core components of integrated care for people with kidney failure

Author

Davison, Sara N., Pommer, Wolfgang, Brown, Mark A., Douglas, Claire A., Gelfand, Samantha L., Gueco, Irmingarda P., Hole, Barnaby D., Homma, Sumiko, Kazancıoğlu, Rümeyza T., Kitamura, Harumi, Koubar, Sahar H., Krause, Rene, Li, Kelly C., Lowney, Aoife C., Nagaraju, Shankar P., Niang, Abdou, Obrador, Gregorio T., Ohtake, Yoichi, Schell, Jane O., Scherer, Jennifer S., Smyth, Brendan, Tamba, Kaichiro, Vallath, Nandini, Wearne, Nicola, Zakharova, Elena, Zúñiga, Carlos, and Brennan, Frank P.

Published
2024
Full Text
View/download PDF

5. Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Author

Abrahams, Alferso C., Anumudu, Samaya J., Bargman, Joanne M., Moore, Geraldine Biddle, Blake, Peter G., Borman, Natalie, Bowes, Elaine, Burton, James O., Caillette-Beaudoin, Agnes, Cho, Yeoungjee, Cullis, Brett, Einbinder, Yael, el Shamy, Osama, Erickson, Kevin F., Figueiredo, Ana E., Finkelstein, Fred, Fluck, Richard, Flythe, Jennifer E., Fotheringham, James, Fukagawa, Masafumi, Goffin, Eric, Golper, Thomas A., Gómez, Rafael, Jha, Vivekanand, Johnson, David W., Kanjanabuch, Talerngsak, Kim, Yong-Lim, Lambie, Mark, Lerma, Edgar V., Lockridge, Robert S., Loud, Fiona, Masakane, Ikuto, Matthews, Nicola, McKane, Will, Mendelssohn, David C., Mettang, Thomas, Mitra, Sandip, Moraes, Thyago Proença de, Morton, Rachael, Mushahar, Lily, Nadeau-Fredette, Annie-Claire, Nayak, K.S., Neumann, Joanna L., Ngaruiya, Grace, Okpechi, Ikechi, Quinn, Robert R., Rangaswami, Janani, Reddy, Yuvaram N.V., Schiller, Brigitte, Shen, Jenny I., Shroff, Rukshana, Slon Roblero, Maria Fernanda, Solá, Laura, Søndergaard, Henning, Teitelbaum, Isaac, Tennankore, Karthik, Van Ommeslaeghe, Floris, Walker, Rachael C., Walker, Robert J., Wang, Angela Yee-Moon, Warady, Bradley A., Watnick, Suzanne, Weinhandl, Eric D., Wilkie, Caroline M., Williams, Jennifer, Perl, Jeffrey, Brown, Edwina A., Chan, Christopher T., Couchoud, Cécile, Davies, Simon J., Kazancioğlu, Rümeyza, Klarenbach, Scott, Liew, Adrian, Weiner, Daniel E., Cheung, Michael, Jadoul, Michel, Winkelmayer, Wolfgang C., and Wilkie, Martin E.

Published
2023
Full Text
View/download PDF

6. Trends of primary glomerular disease in Turkey: TSN-GOLD registry report

Author

Gül, Cuma Bülent, Küçük, Mehmet, Öztürk, Savaş, Demir, Erol, Eren, Necmi, Şumnu, Abdullah, Seyahi, Nurhan, Güllülü, Mustafa, Dede, Fatih, Derici, Ülver, Koç, Yener, Şahin, Garip, Oymak, Oktay, Sahin, Gülizar Manga, Tatar, Erhan, Dursun, Belda, Dheir, Hamad, Apaydın, Süheyla, Süleymanlar, Gültekin, Ulu, Sena, Altınören, Orçun, Kutlay, Sim, Meşe, Meral, Şahin, İdris, Üstündağ, Sedat, Türkmen, Kültigin, Yılmaz, Mehmet Emin, Kazancıoğlu, Rümeyza Turan, Uzun, Özcan, Candan, Ferhan, Aydın, Zeki, Oygar, Deren, Aktaş, Nimet, Erdem, Yunus, Paydaş, Saime, Taymez, Dilek, Can, Başak, Kıykım, Ahmet, Koç, Leyla, Sezer, Siren, Duranay, Murat, Bardak, Simge, Altıntepe, Lütfullah, Kaya, Burcu, Azak, Alper, Ecder, Sebahat Alışır, Çavdar, Caner, and Selçuk, Nedim Yılmaz

Published
2022
Full Text
View/download PDF

7. KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation

Author

Abu-Alfa, Ali K., Amer, Hatem, Beutel, Gernot, Chapman, Jeremy, Chen, Xiaohong, Chudek, Jerzy, Cosmai, Laura, Danesi, Romano, De Stefano, Filippo, Iseki, Kunitoshi, Jaimes, Edgar A., Jhaveri, Kenar D., Jurczyszyn, Artur, Kazancioğlu, Rümeyza, Kitchlu, Abhijat, Kollmannsberger, Christian, Lahoti, Amit, Li, Yang, Macía, Manuel, Matsubara, Takeshi, Mitropoulos, Dionysios, Noiri, Eisei, Perazella, Mark A., Ronco, Pierre, Rosner, Mitchell H., Soler Romeo, Maria Jose, Sprangers, Ben, Stadler, Walter M., Stevens, Paul E., Tesař, Vladimír, Torres da Costa e Silva, Verônica, Vesole, David H., Vijayan, Anitha, Viklický, Ondřej, Workeneh, Biruh T., Yanagita, Motoko, Zakharova, Elena, Małyszko, Jolanta, Bamias, Aristotelis, Danesh, Farhad R., Dębska-Ślizień, Alicja, Gallieni, Maurizio, Gertz, Morie A., Kielstein, Jan T., Tesarova, Petra, Wong, Germaine, Cheung, Michael, Wheeler, David C., Winkelmayer, Wolfgang C., and Porta, Camillo

Published
2020
Full Text
View/download PDF

8. KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

Author

Abu-Alfa, Ali K., Amer, Hatem, Beutel, Gernot, Chapman, Jeremy, Chen, Xiaohong, Chudek, Jerzy, Cosmai, Laura, Danesi, Romano, De Stefano, Filippo, Iseki, Kunitoshi, Jaimes, Edgar A., Jhaveri, Kenar D., Jurczyszyn, Artur, Kazancioğlu, Rümeyza, Kitchlu, Abhijat, Kollmannsberger, Christian, Lahoti, Amit, Li, Yang, Macía, Manuel, Matsubara, Takeshi, Mitropoulos, Dionysios, Noiri, Eisei, Perazella, Mark A., Ronco, Pierre, Rosner, Mitchell H., Soler Romeo, Maria Jose, Sprangers, Ben, Stadler, Walter M., Stevens, Paul E., ladimír Tesař, Torres da Costa e Silva, Verônica, Vesole, David H., Vijayan, Anitha, Viklický, Ondřej, Workeneh, Biruh T., Yanagita, Motoko, Zakharova, Elena, Porta, Camillo, Bamias, Aristotelis, Danesh, Farhad R., Dębska-Ślizień, Alicja, Gallieni, Maurizio, Gertz, Morie A., Kielstein, Jan T., Tesarova, Petra, Wong, Germaine, Cheung, Michael, Wheeler, David C., Winkelmayer, Wolfgang C., and Małyszko, Jolanta

Published
2020
Full Text
View/download PDF

9. Post-COVID-19 Outcomes of Patients with Primary Glomerular Diseases: A Nationwide Controlled Study.

Author

Öztürk, Savaş, Karadağ, Serhat, Arıcı, Mustafa, Türkmen, Aydın, Turgutalp, Kenan, Aktaş, Nimet, Kazancıoğlu, Rümeyza, Kuzu, Tolga, Öztürk, İlyas, Aydın, Zeki, Ayar, Yavuz, Mutluay, Rüya, Ebinç, Fatma Ayerden, Pınar, Musa, Bastürk, Taner, Yılmaz, Fatih, İnci, Ayça, Trabulus, Sinan, Ural, Zeynep, and Pembegül, İrem

Subjects
KIDNEY glomerulus diseases, COVID-19 pandemic, COVID-19, RENAL replacement therapy, CHRONIC kidney failure, TERMINALLY ill, GOVERNORS
Abstract

Background: Patients with chronic diseases such as chronic kidney disease (CKD) have been reported to have more adverse outcomes during the coronavirus disease 2019 (COVID-19) pandemic. There are insuficient data on the outcomes of patients with primary glomerular diseases (PGD) afer COVID-19. Methods: We designed a national multicenter observational study that included adult patients with biopsy-proven PGD who survived COVID-19. A control group was created from the same centers, including PGD patients without COVID-19. The clinical and laboratory data of the patients at baseline, frst, and third months afer COVID-19 were recorded. Results: A total of 129 patients from 21 centers were included (COVID-19 group, n = 77). Baseline characteristics were almost similar except the ratio of active disease in the non-COVID-19 group was signifcantly higher than in the COVID-19 group. No patients died during the frst and third months. Respiratory symptoms were signifcantly higher in the COVID-19 group than in the non-COVID-19 group in the frst month (7.8% vs. 0%, P = .039). All other follow-up outcomes, including initiation of chronic kidney replacement therapy and initiation of new immunosuppressive treatment, and the laboratory data were not diferent between the groups in the frst and third months. Conclusion: Primary glomerular disease patients in the post-COVID-19 period had more respiratory symptoms than non-COVID-19 PGD patients, but outcomes, including death and initiation of kidney replacement therapy, were not diferent in the frst and third months post COVID-19. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Capacity for the management of kidney failure in the International Society of Nephrology Eastern and Central Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

Author

Alparslan, Caner, Malyszko, Jolanta, Caskey, Fergus J., Aleckovic-Halilovic, Mirna, Hrušková, Zdenka, Arruebo, Silvia, Bello, Aminu K., Damster, Sandrine, Donner, Jo-Ann, Jha, Vivekanand, Johnson, David W., Levin, Adeera, Malik, Charu, Nangaku, Masaomi, Okpechi, Ikechi G., Tonelli, Marcello, Ye, Feng, Tesar, Vladimir, Racki, Sanjin, Amouzegar, Atefeh, Aydin, Zehra, Barbullushi, Myftar, Bek, Sibel, Bumblyte, Inga Arune, Cho, Yeoungjee, Davids, M. Razeen, Davison, Sara N., Deltas, Constantinos, Diongole, Hassane M., Divyaveer, Smita, Ekrikpo, Udeme E., Ethier, Isabelle, Fogo, Agnes B., Wing-Shing Fung, Winston, Ghimire, Anukul, Honsova, Eva, Houston, Ghenette, Htay, Htay, Ibrahim, Kwaifa Salihu, Irish, Georgina, Jindal, Kailash, Kazancıoğlu, Rümeyza, Kelly, Dearbhla M., Krajewska, Magdalena, Laganovic, Mario, Lalji, Rowena, Nalado, Aisha M., Naumovic, Radomir, Neuen, Brendon L., Nikolova-Vlahova, Milena Krasimirova, Nistor, Ionut, Olanrewaju, Timothy O., Osman, Mohamed A., Ots-Rosenberg, Mai, Petrova, Anna, Podracka, Ludmila, Resic, Halima, Riaz, Parnian, Rosivall, Laszlo, Saad, Syed, Sakajiki, Aminu Muhammad, See, Emily, Sever, Mehmet Sukru, Sozio, Stephen M., Spasovski, Goce, Tiv, Sophanny, Tuglular, Serhan, Tungsanga, Somkanya, Viecelli, Andrea, Wainstein, Marina, Yeung, Emily K., and Zaidi, Deenaz

Abstract

Delivery of care for kidney failure (KF) globally has a significant disparity; even in some countries, it means end of life for the person. The International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) tries to address gaps in KF care and standardize global nephrology care. From the third iteration of the ISN-GKHA, we present data for countries in the ISN Eastern and Central Europe region. The median prevalences of chronic kidney disease (12.8%) and treated KF (873.5 pmp) were higher than the global rates, respectively. Hemodialysis was the most preferred modality for KF in adults, whereas kidney replacement therapy was more balanced in children. Although most of the countries in the region had lower-middle–income and upper-middle–income levels, health expenditures for kidney health care were almost generally covered publicly. Nephrologists were responsible for the medical kidney care of people with KF in all countries. There was adequate infrastructure to provide all kinds of treatment for kidney care in the region. Regional characteristics such as high levels of obesity, smoking, and Balkan nephropathy as an endemic disease coupled with a shortage of workforce and finance continued to affect kidney care in the region negatively. By making organizational and legislative arrangements, partnerships with national authorities and societies may accelerate the improvement of kidney health care in the region.

Published
2024
Full Text
View/download PDF

11. Resilience of hospital in disaster.

Author

Kazancıoğlu, Rümeyza and Erdoğan, Özcan

Subjects
DISASTER resilience, NATURAL disasters, EMERGENCY management, MEDICAL care, HUMAN resources departments, EARTHQUAKES
Abstract

Disasters and crisis situations are unforeseen events. When a disaster occurs, the most critical step after the intervention at the scene is the health and treatment services provided in hospitals. Since it is of vital importance that hospitals, where health services are provided, are accessible and operational when faced with natural and man-made disasters such as earthquakes, fires, epidemics, CBRN events, wars, and crises such as cyber-attacks, economic problems, hospitals must protect themselves against a disaster hazard and plan what to do during and after the disaster. This review was written to emphasize the importance of hospitals and their resilience in times of crisis and disaster.Hospitals can enhance their resilience by strengthening both their physical and social aspects. It is essential to create resistance in hospitals not against specific dangers such as fire and earthquake, but against all crises that may occur in the system. A hospital must first identify its structural and non-structural risks to enhance its physical resilience. To enhance social resilience, a hospital should plan its organisations and human resources, establish accurate information communication, and engage in logistics and financial planning. It is crucial to guarantee uninterrupted patient care and all supportive services. Measures should be taken for decontamination and evacuation of patients when necessary while also ensuring the overall security of the hospital. As a result, hospital resilience plays a critical role in maintaining healthcare services, effectively managing emergencies, and generally protecting public health. Further studies are needed to strengthen this resistance. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

13. Challenges and Solutions for Data Collection Related to Nephrological Problems Following Disasters.

Author

Tuğlular, Serhan Zubeyde, Öztürk, Savaş, Kazancıoğlu, Rümeyza, and Sever, Mehmet Şükrü

Subjects
ACQUISITION of data, HEALTH information systems, DISASTER victims, DISASTERS, DATA warehousing, HOSPITALS
Abstract

Although collecting scientific data during disaster conditions may be very challenging and not considered a priority, it is crucial since it may serve to shed light on similar future disaster conditions. The primary obstacles in data collection fall into 2 main categories: (i) the recording process itself and (ii) the reliability of the test results. During and after crisis periods, data collection is complicated by various factors. These include a sudden and significant surge in patient numbers, disruptions in hospital operational systems, health-care professionals experiencing burnout, inadequate examination of incoming disaster victims, rapid patient transfers to other health-care facilities, and infrastructural damage affecting the operation of hospital health information systems. These challenges collectively lead to inaccuracies in hospital data collection and storage processes. The reliability and interpretation of even the basic test results may be hampered by functional disruption of the laboratory systems, mixing of patients’ lab results due to overburden of patients, and lack of identification information as well as incorrectly abnormal values due to inadequate preanalytical and analytical processes. This opinion article discusses health-care professionals’ data collection challenges regarding kidney problems during large-scale disasters and suggests solutions to overcome these problems. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

14. Comparison of Renal and Metabolic Effects of Empagliflozin and Dapagliflozin on Type 2 Diabetes-Induced Rats

Author

Kazancıoğlu, Rümeyza, Herdan, Nadir Emre, Gürsu, Meltem, Çoban, Ganime, Selek, Şahabettin, SELEK, ŞAHABETTİN, KAZANCIOĞLU, Rümeyza, ÇOBAN, GANİME, and GÜRSU, Meltem

Subjects
Herdan N. E. , Gürsu M., Çoban G., Selek Ş., Kazancıoğlu R., -Comparison of Renal and Metabolic Effects of Empagliflozin and Dapagliflozin on Type 2 Diabetes-Induced Rats-, American Society of Nephrology /Kidney Week 2022, California, Amerika Birleşik Devletleri, 3 - 06 Kasım 2022, ss.663
Published
2022

16. Covid-19-un akut böbrek hasar belirteçleri uzerine etkisi

Author

Kazancıoğlu, Rümeyza, Akkoyunlu, Yasemin, Aslan, Turan, Güler, Eray Metin, Koçyiğit, Abdürrahim, Elçioğlu, Ömer Celal, Bolukçu, Sibel, Okay, Gülay, Durdu, Bülent, Sümbül, Bilge, KAZANCIOĞLU, Rümeyza, SÜMBÜL, BİLGE, DURDU, BÜLENT, OKAY, GÜLAY, ELÇİOĞLU, Ömer Celal, KOÇYİĞİT, ABDÜRRAHİM, AKKOYUNLU, YASEMİN, and ASLAN, TURAN

Subjects
Akkoyunlu Y., Koçyiğit A., Elçioğlu Ö. C. , Güler E. M. , Sümbül B., Okay G., Durdu B., Bolukçu S., Kazancıoğlu R., Aslan T., -Covid-19-un akut böbrek hasar belirteçleri uzerine etkisi-, 10. EKMUD Bilimsel Kongresi , Antalya, Türkiye, 25 - 29 Mayıs 2022, ss.1-2
Published
2022

17. Predisposing Metabolic Factors to Urinary System Stone Formation in Patients with Autosomal Dominant Polycystic Kidney Disease

Author

Elçioğlu, Ömer Celal, Chasan, Onour, Kazancıoğlu, Rümeyza, Mirioğlu, Şafak, Artan, Ayşe Serra, Gürsu, Meltem, ELÇİOĞLU, Ömer Celal, KAZANCIOĞLU, Rümeyza, GÜRSU, Meltem, and MİRİOĞLU, ŞAFAK

Subjects
Chasan O., Artan A. S. , Gürsu M., Mirioğlu Ş., Kazancıoğlu R., Elçioğlu Ö. C. , -Predisposing Metabolic Factors to Urinary System Stone Formation in Patients with Autosomal Dominant Polycystic Kidney Disease-, 59th ERA Congress, Paris, Fransa, 19 - 22 Mayıs 2022, cilt.37, ss.74
Published
2022

18. COVID-19 Infection in Peritoneal Dialysis Patients: A Comparative Outcome Study with Patients on Hemodialysis and Patients without Kidney Disease

Author

Kazancıoğlu, Rümeyza, Öztürk, Savaş, Turgutalp, Kenan, Gürsu, Meltem, Arıcı, Mustafa, Gibyeli Genek, Dilek, MÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, and Gibyeli Genek, Dilek

Subjects
Hemodialysis, Peritoneal dialysis, COVID-19, Outcome
Abstract

Objectives: There is limited data about coronavirus disease-19 (COVID-19) characteristics and results in peritoneal dialysis (PD) patients. This study aimed to investigate the characteristics and outcomes among PD patients and compare them with matched hemodialysis (HD) patients and a control group without kidney disease. Methods: We included 18 PD patients and consecutive age- and gender-matched 18 HD and 18 patients without kidney disease (control group) registered into the Turkish Society of Nephrology database including 1301 COVID-19 patients. We compared demographic, clinical, radiological, laboratory data, and outcomes namely intensive care unit (ICU) admission, mechanical ventilation, mortality, and composite outcome (death and/or ICU admission). Results: ICU admission, mechanical ventilation, and mortality rates in PD patients (27.8%, 22.2%, and 22.2%, respectively) and the HD group (16.7%, 11.1%, and 16.7%, respectively) were higher than the control group (11.1%, 11.1%, and 5.6%, respectively), but intergroup comparison did not reveal difference. A total of 11 (20.3%) patients had composite outcome (6 PD patients, 3 HD patients, and 2 patients in the control group). In Cox regression analysis, higher age and higher CRP level were related to increased risk of composite outcome. Adjusted rate of composite outcome in PD group was significantly higher than the control group (P =.050). This rate was similar in HD and control groups (P =.30). Conclusions: Combined in-hospital mortality and/or ICU admission of PD patients with COVID-19 was significantly higher than the control patients. There is a need for careful surveillance of PD patients for infection signs and prompt treatment of COVID-19.

Published
2022

19. SERUM PARAOXONASE ACTIVITY AND PHENOTYPE DISTRIBUTION IN TURKISH COVID-19 PATIENTS

Author

Selek, Şahabettin, Kazancıoğlu, Rümeyza, Gülen, Bedia, Çelik, Halil İsa, Doymaz, Mehmet Ziya, Okay, Gülay, Yurtsever, Ismail, Sarıkaya, Ufuk, Metin, Hüseyin, Sönmez, Ertan, Taşlıdere, Bahadır, and OKAY, GÜLAY

Subjects
Gülen B., Selek Ş., Çelik H. İ. , Taşlıdere B., Sönmez E., Metin H., Sarıkaya U., Yurtsever I., Okay G., Doymaz M. Z. , et al., -SERUM PARAOXONASE ACTIVITY AND PHENOTYPE DISTRIBUTION IN TURKISH COVID-19 PATIENTS-, 8th INTERCONTINENTAL EMERGENCY MEDICINE CONGRESS 8th INTERNATIONAL CRITICAL CARE AND EMERGENCY MEDICINE CONGRESS, Antalya, Türkiye, 14 - 17 Ekim 2021, ss.152-153
Published
2021

20. Otozomal Dominant Polikistik Böbrek Hastalarında Üriner Sistem Taşı Oluşumuna Eğilim Oluşturan Metabolik Faktörler

Author

Artan, Ayşe Serra, Elçioğlu, Ömer Celal, Kazancıoğlu, Rümeyza, Gürsu, Meltem, Chasan, Onour, Mirioğlu, Şafak, and CHASAN, ONOUR

Subjects
Chasan O., Artan A. S. , Gürsu M., Mirioğlu Ş., Kazancıoğlu R., Elçioğlu Ö. C. , -Otozomal Dominant Polikistik Böbrek Hastalarında Üriner Sistem Taşı Oluşumuna Eğilim Oluşturan Metabolik Faktörler-, 38. Ulusal Nefroloji Kongresi, Girne, Kıbrıs (Kktc), 13 - 17 Ekim 2021, ss.30
Published
2021

21. Kronik Böbrek Hastasında Covid-19 Enfeksiyonu Sonrası Gelişen Nefrotik Sendrom: Olgu Sunumu

Author

Abdulhayoğlu, Necat İrem, Kazancıoğlu, Rümeyza, Mirioğlu, Şafak, Elçioğlu, Ömer Celal, Gürsu, Meltem, and ABDULHAYOĞLU, NECAT İREM

Subjects
Olgu Sunumu-, 38. Ulusal Nefroloji Kongresi, Girne, Kıbrıs (Kktc), 13 - 17 Ekim 2021, ss.67 [Abdulhayoğlu N. İ. , Gürsu M., Elçioğlu Ö. C. , Mirioğlu Ş., Kazancıoğlu R., -Kronik Böbrek Hastasında Covid-19 Enfeksiyonu Sonrası Gelişen Nefrotik Sendrom]
Published
2021

22. Otozomal Dominant Polikistik Böbrek Hastalığında Total Oksidan/Antioksidan Seviyelerin Böbrek Fonksiyonlarıyla İlişkisi

Author

Aris, Özlem, Gürsu, Meltem, Mirioğlu, Şafak, Artan, Ayşe Serra, Büyükaydın, Banu, Elçioğlu, Ömer Celal, Kazancıoğlu, Rümeyza, and GÜRSU, Meltem

Subjects
Aris Ö., Büyükaydın B., Artan A. S. , Mirioğlu Ş., Gürsu M., Kazancıoğlu R., Elçioğlu Ö. C. , -Otozomal Dominant Polikistik Böbrek Hastalığında Total Oksidan/Antioksidan Seviyelerin Böbrek Fonksiyonlarıyla İlişkisi-, 38. Ulusal Nefroloji Kongresi, Girne, Kıbrıs (Kktc), 13 - 17 Ekim 2021, ss.31
Published
2021

23. COVİD-19 PANDEMİSİNDE Hastalık/Hastane Yönetimi

Author

Kazancıoğlu, Rümeyza and KAZANCIOĞLU, Rümeyza

Subjects
Kazancıoğlu R., COVİD-19 PANDEMİSİNDE KRONİK BÖBREK YETMEZLİĞİ OLAN HASTALARIN TEDAVİSİ VE DİYALİZ HASTALARIN YÖNETİMİ, -COVİD-19 PANDEMİSİNDE Hastalık/Hastane Yönetimi-, Ramazan Özdemir,Teoman Aydın,Özlem Su Küçük, Editör, Genel Satış Pazarlama ve Yayınevi, İstanbul, ss.345-354, 2021
Published
2021

24. The relationship between glomerular IgG staining and poor prognostic findings in patients with IgA nephropathy: the data from TSN-GOLD working group

Author

Turgutalp, Kenan, Cebeci, Egemen, Türkmen, Aydın, Derici, Ülver Boztepe, Seyahi, Nurhan, Eren, Necmi, Dede, Fatih, Güllülü, Mustafa, Baştürk, Taner, Şahin, Gülizar Manga, Yılmaz, Mürvet, Sipahi, Savaş, Şahin, Garip, Ulu, Sena Memnune, Tatar, Erhan, Gündogdu, Ali, Kazancıoğlu, Rümeyza Turan, Sevinç, Can, Güngör, Özkan, Şahin, İdris, Kutlay, Sim, Kurultak, İlhan, Aydın, Zeki, Altun, Bülent, Dursun, Belda, Yılmaz, Zülfükar, Uzun, Özcan, Süleymanlar, Gültekin, Candan, Ferhan, Sezer, Siren, Tanburoğlu, Derya Basak, Bicik, Zerrin, Taymez, Dilek Güven, Akcali, Esra, Oygar, Düriye Deren, İstemihan, Zülal, Bardak, Simge, Akçay, Ömer Faruk, Dincer, Mevlüt Tamer, Dervişoğlu, Erkan, Yenigün, Ezgi Çoşkun, Türkmen, Kültigin, Özturk, Savaş, KAZANCIOĞLU, Rümeyza, Basturk, Taner, Ulu, Sena, Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıklar Ana Bilim Dalı, and Yılmaz, Zülfükar

Subjects
Nephrology, Adult, Male, medicine.medical_specialty, Kidney Glomerulus, urologic and male genital diseases, Gastroenterology, Oxford Classification, Nephropathy, Glomerular IgG staining, chemistry.chemical_compound, Internal medicine, Biopsy, medicine, Humans, Deposition, Retrospective Studies, O-Glycosylation, Proteinuria, medicine.diagnostic_test, Staining and Labeling, business.industry, Research, Glomerular mesangium, Albumin, Glomerulonephritis, IGA, IgA nephropathy, Middle Aged, medicine.disease, Prognosis, the data from TSN-GOLD working group.-, BMC nephrology, cilt.22, sa.1, ss.352, 2021 [Turgutalp K., Cebeci E., Turkmen A., Derici U., Seyahi N., Eren N., Dede F., Gullulu M., Basturk T., Sahin G. M. , et al., -The relationship between glomerular IgG staining and poor prognostic findings in patients with IgA nephropathy], Diseases of the genitourinary system. Urology, Cross-Sectional Studies, chemistry, Immunoglobulin G, Uric acid, Mesangial proliferative glomerulonephritis, Female, RC870-923, medicine.symptom, business, Renal prognostic factors
Abstract

Background Galactose-deficient IgA1 (Gd-IgA1) has an increased tendency to form immunocomplexes with IgG in the serum, contributing to IgAN pathogenesis by accumulating in the glomerular mesangium. Several studies showed that glomerular IgG deposition in IgAN is an important cause of mesangial proliferation and glomerular damage. This study aims to determine the association of the positivity of IgG and the intensity of IgG staining with a poor renal prognosis. Methods A total of 943 IgAN patients were included in the study. Glomerular IgG staining negative and positive patients were compared using Oxford classification scores, histopathological evaluations, proteinuria, eGFR, albumin, blood pressures. IgG positive patients were classified as (+), (++), (+++) based on their staining intensity, and the association with the prognostic criteria was also evaluated. Results 81% (n = 764) of the patients were detected as IgG negative, while 19% (n = 179) were positive. Age, gender, body mass index, blood pressure, proteinuria, eGFR, uric acid values were similar in IgG positive and negative patients who underwent biopsy (p > 0.05). Intensity of glomerular IgG positivity was not found to be associated with diastolic and systolic blood pressure, urea, uric acid, age, eGFR, albumin, proteinuria (p > 0.05 for all, r = − 0.084, r = − 0.102, r = − 0.006, r = 0.062, r = 0.014, r = − 0.044, r = − 0.061, r = − 0.066, r = 0.150, respectively). There was no difference for histopathological findings between IgG (+), IgG (++), IgG (+++) groups (for all, p > 0.05). Conclusion Glomerular IgG negativity and positivity detected by routine IFM in IgAN patients is not associated with poor renal prognostic risk factors.

Published
2021

25. Periton Diyalizi Hastasının Yönetimi

Author

Ersoy, F Fevzi, Kazancıoğlu, Rümeyza, Ateş, Kenan, Ünal, Aydın, Tokgöz, Bülent, and KAZANCIOĞLU, Rümeyza

Subjects
Ersoy F. F. (Editör), Ateş K. (Editör), Kazancıoğlu R. (Editör), Tokgöz B. (Editör), Ünal A. (Editör), Periton Diyalizi Hastasının Yönetimi, Güneş Tıp Kitapevleri, Ankara, 2021
Published
2021

26. Nefroloji Kitabı Cilt 2

Author

Kazancıoğlu, Rümeyza and KAZANCIOĞLU, Rümeyza

Subjects
Kazancıoğlu R., Periton Diyalizinin Enfeksiyöz Komplikasyonları, -Nefroloji Kitabı Cilt 2-, Özkan Güngör,İsmail Koçyiğit,Sena Ulu,Bülent Tokgöz,Mustafa Arıcı,Kenan Ateş, Editör, Akademisyen Kitapevi A.Ş., Ankara, ss.1409-1418, 2021
Published
2021

28. Nefroloji Kitabı

Author

Altunören, Orçun, primary, Bekfilavioğlu, Garip, additional, Önal, Ceren, additional, Altun, Bülent, additional, Akpolat, Tekin, additional, Ok, Ebru Sevinç, additional, Mengüş, Çiğdem, additional, Yalçın, Ahmet Uğur, additional, Turgutalp, Kenan, additional, Özer, Caner, additional, Temiz, Gökhan, additional, Bozacı, İlter, additional, Ünal, Aydın, additional, Sipahioğlu, Murat Hayri, additional, Güngör, Özkan, additional, Koyuncu, Sümeyra, additional, Gökalp, Cenk, additional, Koçyiğit, İsmail, additional, Duman, Soner, additional, Ulu, Sena, additional, Tokgöz, Bülent, additional, Arıcı, Mustafa, additional, Ateş, Kenan, additional, Aktürk, Serkan, additional, Dede, Fatih, additional, Kürşat, Seyhun, additional, Ecder, Tevfik, additional, Uysal, Cihan, additional, Onan, Engin, additional, Gürkan Toçoğlu, Aysel, additional, Sipahi, Savaş, additional, Külah, Eyüp, additional, Aydın, Zeki, additional, Helvacı, Özant, additional, Güz, Galip, additional, Sifil, Aykut, additional, Aydar, Halil, additional, Şahin, Garip, additional, Seziş Demirci, Meltem, additional, Atay, Gökhan, additional, Tuğlular, Serhan, additional, Cebeci, Egemen, additional, Arıkan, İzzet Hakkı, additional, Artunç, Ferruh, additional, Gürsu, Meltem, additional, Öztürk, Savaş, additional, Bicik Bahçebaşı, Zerrin, additional, Yıldız, Abdülmecit, additional, Dirim, Ahmet Burak, additional, Çalışkan, Yaşar, additional, Sayarlıoğlu, Hayriye, additional, Algül Durak, Beyza, additional, Tutal, Emre, additional, Dilek, Kamil, additional, Eren, Necmi, additional, Bakırdöğen, Serkan, additional, Güllülü, Mustafa, additional, Turgut, Didem, additional, Türkmen, Kültigin, additional, Baloğlu, İsmail, additional, Koç, Neriman Sıla, additional, Kaynar, R. Kübra, additional, Torun, Dilek, additional, Paydaş, Saime, additional, Turgut, Faruk Hilmi, additional, Türkmen, Ercan, additional, Arık, Nurol, additional, Ulusoy, Şükrü, additional, Özkan, Gülsüm, additional, Akoğlu, Hadim, additional, Hacıoğlu, Ayşa, additional, Karaca, Züleyha, additional, Uçar, Ali Rıza, additional, Yazıcı, Halil, additional, Öneç, Kürşad, additional, Boztepe Derici, Ülve, additional, Oto, Özgür Akın, additional, İnci, Ayça, additional, Ayerden Ebinç, Fatma, additional, Coşkun Yavuz, Yasemin, additional, Pembegül, İrem, additional, Eroğlu, Eray, additional, Çetinkaya, Ramazan, additional, Seyahi, Nurhan, additional, Özcan, Şeyda Gül, additional, Kadiroğlu, Ali Kemal, additional, Gürel, Ali, additional, Doğukan, Ayhan, additional, Akdam, Hakan, additional, Akar, Harun, additional, Batuman, Vecihi, additional, Güçlü, Aydın, additional, Sağlam, Funda, additional, Tezcan, Neslihan, additional, Mutluay, Rüya, additional, Sarı, Funda, additional, Dursun, Belda, additional, Gün, Yelda, additional, Yeniçerioğlu, Yavuz, additional, İkizler, T. Alp, additional, Sever, Mehmet Şükrü, additional, Şahutoğlu, Tuncay, additional, Kara, Ekrem, additional, Usalan, Özlem, additional, Özdemir, Orhan, additional, Gül, Cuma Bülent, additional, Azak, Alper, additional, Kazan, Sinan, additional, Hüddam, Bülent, additional, Tatar, Erhan, additional, Çopur, Sidar, additional, Kanbay, Mehmet, additional, Hür, Ender, additional, Toraman, Aysun, additional, Süleymanlar, Gültekin, additional, Bayrakçı, Nergiz, additional, Şaşak Kuzgun, Gülşah, additional, Odabaş, Ali Rıza, additional, Ulusal Okyay, Gülay, additional, Arınsoy, Turgay, additional, Akkaş, Erhan, additional, Sezer, Siren, additional, Duranay, Murat, additional, Büberci, Refika, additional, Turgut, Aslı, additional, Taşkapan, Hülya, additional, Utaş, Serap, additional, Yıldırım, Tolga, additional, Müge Değer, Serpil, additional, Demirtaş, Gülay, additional, Oymak, Oktay, additional, Yenicesu, Müjdat, additional, Eren Sadioğlu, Rezzan, additional, Duman, Neval, additional, Tonbul, H. Zeki, additional, Ok, Ercan, additional, Çağlar, Kayser, additional, Ersoy, F. Fevzi, additional, Dinçer, Tamer, additional, Ataman, Rezzan, additional, Aşıcıoğlu, Ebru, additional, Özener, Çetin, additional, Çamsarı, Taner, additional, Oktan, Mehmet Ası, additional, Kazancıoğlu, Rümeyza, additional, Yılmaz, Mehmet Emin, additional, Yılmaz, Zülfükar, additional, Türkmen, Aydın, additional, Demir, Erol, additional, Özkök, Abdullah, additional, Yıldız, Alaattin, additional, Koçak, Hüseyin, additional, Yılmaz, Vural Taner, additional, Bozacı, Ali Cansu, additional, Aki, Fazıl Tuncay, additional, Şen, Sait, additional, Töz, Hüseyin, additional, Göral, Simin, additional, Yılmaz, Rahmi, additional, Çakır, Ülkem, additional, Koç, Mehmet, additional, Tuğcu, Murat, additional, Gök Oğuz, Ebru, additional, Alagöz, Selma, additional, Trabulus, Sinan, additional, Afşar, Barış, additional, Olmaz, Refik, additional, Altıparmak, Mehmet Rıza, additional, Alışır Ecder, Sabahat, additional, Kıykım, Ahmet, additional, Bardak, Simge, additional, and Hasbal, Nuri Barış, additional

Published
2021
Full Text
View/download PDF

29. Orthostatic Hypotension in Older Adults

Author

Büyükaydın, Banu, Kazancıoğlu, Rümeyza, and KAZANCIOĞLU, Rümeyza

Subjects
Büyükaydın B., Kazancıoğlu R., Prevention and Treatment, -Orthostatic Hypotension in Older Adults -, Ahmet Turan Işık,Pınar Soysal, Editör, Springer, London/Berlin , Basel, ss.105-112, 2021
Published
2020

30. Effects of a Change in the Definition of Chronic Kidney Disease on Geriatric Assessment Parameters.

Author

Heybeli, Cihan, Soysal, Pınar, Smith, Lee, Keskin, Elmas Biberci, and Kazancıoğlu, Rümeyza

Subjects
CHRONIC kidney failure, GERIATRIC assessment, FRAIL elderly, CHRONICALLY ill, NUTRITIONAL assessment, GLOMERULAR filtration rate, ACTIVITIES of daily living
Abstract

Objectives: Geriatric syndromes are common in elderly subjects with chronic kidney disease. An age-adapted definition of chronic kidney disease has recently been proposed. This study aimed to investigate the effects of this change in the definition of chronic kidney disease (from an estimated glomerular filtration rate of <60 to <45 mL/min/1.73 m² ) on geriatric assessments. Methods: Records of an elderly outpatient population were retrospectively reviewed. Subjects underwent comprehensive geriatric assessment including the Basic and Instrumental Activities of Daily Living, Mini-Mental State Examination, Geriatric Depression Score, Tinetti Mobility test, the Timed Up and Go test, the Mini Nutritional Assessment, the handgrip test, and the Insomnia Severity Index. Logistic regression analysis was performed in order to determine the odds ratio of each chronic kidney disease definition on geriatric syndromes. Results: Of the 1222 patients, 832 (68.1%) were women and the median age was 73 (interquartile range, 67-80) years. Patients with an estimated glomerular filtration rate of <45 and <60 mL/min/1.73 m² comprised 8.3% (n = 101) and 21.6% (n = 264) of the cohort, respectively. Both estimated glomerular filtration rates of <45 and <60 mL/min/1.73 m² were significantly associated with more unfavorable geriatric assessment scores in univariate analysis. After adjustments, associations of an estimated glomerular filtration rate <60 mL/min/1.73 m² with the Timed Up and Go test and polypharmacy remained significant; however, none of the geriatric assessment measures remained significantly associated with an estimated glomerular filtration rate of <45 mL/min/1.73 m² . Conclusion: Chronic kidney disease was more significantly associated with impairments in geriatric assessment parameters when the cut-off of estimated glomerular filtration rate for the definition of chronic kidney disease was kept as <60 mL/min/1.73 m² in comparison to modification of <45 mL/min/1.73 m². [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

31. Böbrek naklinde alıcı ve donör LIMS1 uyumsuzluğunun rejeksiyonla ilişkisi

Author

Mirioğlu, Şafak, Çalışkan, Yaşar Kerem, Özlük, Mesude Yasemin, Dirim, Ahmet Burak, Aksoy, Elif, Demir, Erol, Oto, Özgür Akın, Kazancıoğlu, Rümeyza, Kılıçaslan, Işın, Oğuz, Fatma, Yazıcı, Halil, Türkmen, Aydın, and MİRİOĞLU, ŞAFAK

Subjects
Mirioğlu Ş., Çalışkan Y. K. , Özlük M. Y. , Dirim A. B. , Aksoy E., Demir E., Oto Ö. A. , Kazancıoğlu R., Kılıçaslan I., Oğuz F., et al., -Böbrek naklinde alıcı ve donör LIMS1 uyumsuzluğunun rejeksiyonla ilişkisi-, 37. Ulusal Nefroloji Kongresi, Ankara, Türkiye, 15 - 18 Ekim 2020, ss.48
Published
2020

32. Böbrek nakli alıcılarında LIMS1 genotiplerinin rejeksiyon riskiyle ilişkisi

Author

Mirioğlu, Şafak, Çalışkan, Yaşar Kerem, Özlük, Mesude Yasemin, Dirim, Ahmet Burak, Gürel, Erdem, Demir, Erol, Oto, Özgür Akın, Kazancıoğlu, Rümeyza, Kılıçaslan, Işın, Oğuz, Fatma, Yazıcı, Halil, Türkmen, Aydın, and KAZANCIOĞLU, Rümeyza

Subjects
Mirioğlu Ş., Çalışkan Y. K. , Özlük M. Y. , Dirim A. B. , Gürel E., Demir E., Oto Ö. A. , Kazancıoğlu R., Kılıçaslan I., Oğuz F., et al., -Böbrek nakli alıcılarında LIMS1 genotiplerinin rejeksiyon riskiyle ilişkisi-, 37. Ulusal Nefroloji Kongresi, Ankara, Türkiye, 15 - 18 Ekim 2020, ss.28-29
Published
2020

33. COVID-19 pandemisi sırasında periton diyalizi hastalarında teletıp kullanımı

Author

Gürsu, Meltem, Artan, Ayşe Serra, Elçioğlu, Ömer Celal, Mirioğlu, Şafak, Kazancıoğlu, Rümeyza, and MİRİOĞLU, ŞAFAK

Subjects
Gürsu M., Artan A. S. , Elçioğlu Ö. C. , Mirioğlu Ş., Kazancıoğlu R., -COVID-19 pandemisi sırasında periton diyalizi hastalarında teletıp kullanımı-, 37. Ulusal Nefroloji Kongresi, Ankara, Türkiye, 15 - 18 Ekim 2020, ss.8-9
Published
2020

34. Effects of keto-analogs in the pathologic findings of diabetic nephropatic rats

Author

Kazancıoğlu, Rümeyza, Çoban, Ganime, Gürsu, Meltem, Elçioğlu, Ömer Celal, Deligöz Bilkdacı, Yelda, and ELÇİOĞLU, Ömer Celal

Subjects
Kazancıoğlu R., Çoban G., Gürsu M., Elçioğlu Ö. C. , Deligöz Bilkdacı Y., -Effects of keto-analogs in the pathologic findings of diabetic nephropatic rats-, Turkish Journal of Nephrology, cilt.29, ss.23-27, 2020
Published
2020

35. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey

Author

Yelken, Berna, Öztürk, Savaş; Turgutalp, Kenan; Arıcı, Mustafa; Odabaş, Ali Rıza; Altıparmak, Mehmet Rıza; Aydın, Zeki; Cebeci, Egemen; Baştürk, Taner; Soypaçacı, Zeki; Şahin, Garip; Özler, Tuba Elif; Kara, Ekrem; Dheir, Hamad; Eren, Necmi; Süleymanlar, Gültekin; İslam, Mahmud; Öğütmen, Melike Betül; Şengül, Erkan; Ayar, Yavuz; Dölarslan, Mürşide Esra; Bakırdöğen, Serkan; Şafak, Seda; Güngör, Özkan; Şahin, İdris; Menteşe, İlay Berke; Merhametsiz, Özgür; Oğuz, Ebru Gök; Genek, Dilek Gibyeli; Alpay, Nadir; Aktaş, Nimet; Duranay, Murat; Alagöz, Selma; Çolak, Hülya; Adıbelli, Zelal; Pembegül, İrem; Hür, Ender; Azak, Alper; Taymez, Dilek Güven; Tatar, Erhan; Kazancıoğlu, Rümeyza; Oruç, Ayşegül; Yüksel, Enver; Onan, Engin; Türkmen, Kültigin; Hasbal, Nuri Barış; Gürel, Ali; Sahutoğlu, Tuncay; Gök, Mahmut; Seyahi, Nurhan; Sevinç, Mustafa; Özkurt, Sultan; Sipahi, Savaş; Bek, Sibel Gökçay; Bora, Feyza; Demirelli, Bülent; Oto, Özgür Akın; Altunören, Orçun; Tuğlular, Serhan Zübeyde; Demir, Mehmet Emin; Aylı, Mehmet Deniz; Huddam, Bülent; Tanrısev, Mehmet; Bozacı, İlter; Gürsü, Meltem; Bakar, Betül; Tokgöz, Bülent; Tonbul, Halil Zeki; Yıldız, Alaattin; Sezer, Siren; Ateş, Kenan, Koç University Hospital, Yelken, Berna, Öztürk, Savaş; Turgutalp, Kenan; Arıcı, Mustafa; Odabaş, Ali Rıza; Altıparmak, Mehmet Rıza; Aydın, Zeki; Cebeci, Egemen; Baştürk, Taner; Soypaçacı, Zeki; Şahin, Garip; Özler, Tuba Elif; Kara, Ekrem; Dheir, Hamad; Eren, Necmi; Süleymanlar, Gültekin; İslam, Mahmud; Öğütmen, Melike Betül; Şengül, Erkan; Ayar, Yavuz; Dölarslan, Mürşide Esra; Bakırdöğen, Serkan; Şafak, Seda; Güngör, Özkan; Şahin, İdris; Menteşe, İlay Berke; Merhametsiz, Özgür; Oğuz, Ebru Gök; Genek, Dilek Gibyeli; Alpay, Nadir; Aktaş, Nimet; Duranay, Murat; Alagöz, Selma; Çolak, Hülya; Adıbelli, Zelal; Pembegül, İrem; Hür, Ender; Azak, Alper; Taymez, Dilek Güven; Tatar, Erhan; Kazancıoğlu, Rümeyza; Oruç, Ayşegül; Yüksel, Enver; Onan, Engin; Türkmen, Kültigin; Hasbal, Nuri Barış; Gürel, Ali; Sahutoğlu, Tuncay; Gök, Mahmut; Seyahi, Nurhan; Sevinç, Mustafa; Özkurt, Sultan; Sipahi, Savaş; Bek, Sibel Gökçay; Bora, Feyza; Demirelli, Bülent; Oto, Özgür Akın; Altunören, Orçun; Tuğlular, Serhan Zübeyde; Demir, Mehmet Emin; Aylı, Mehmet Deniz; Huddam, Bülent; Tanrısev, Mehmet; Bozacı, İlter; Gürsü, Meltem; Bakar, Betül; Tokgöz, Bülent; Tonbul, Halil Zeki; Yıldız, Alaattin; Sezer, Siren; Ateş, Kenan, and Koç University Hospital

Abstract

Background: Chronic kidney disease (CKD) and immunosuppression, such as in renal transplantation (RT), stand as one of the established potential risk factors for severe coronavirus disease 2019 (COVID-19). Case morbidity and mortality rates for any type of infection have always been much higher in CKD, haemodialysis (HD) and RT patients than in the general population. A large study comparing COVID-19 outcome in moderate to advanced CKD (Stages 3-5), HD and RT patients with a control group of patients is still lacking. Methods: We conducted a multicentre, retrospective, observational study, involving hospitalized adult patients with COVID-19 from 47 centres in Turkey. Patients with CKD Stages 3-5, chronic HD and RT were compared with patients who had COVID-19 but no kidney disease. Demographics, comorbidities, medications, laboratory tests, COVID-19 treatments and outcome [in-hospital mortality and combined in-hospital outcome mortality or admission to the intensive care unit (ICU)] were compared. Results: A total of 1210 patients were included [median age, 61 (quartile 1-quartile 3 48-71) years, female 551 (45.5%)] composed of four groups: control (n = 450), HD (n = 390), RT (n = 81) and CKD (n = 289). The ICU admission rate was 266/1210 (22.0%). A total of 172/1210 (14.2%) patients died. The ICU admission and in-hospital mortality rates in the CKD group [114/289 (39.4%); 95% confidence interval (CI) 33.9-45.2; and 82/289 (28.4%); 95% CI 23.9-34.5)] were significantly higher than the other groups: HD = 99/390 (25.4%; 95% CI 21.3-29.9; P < 0.001) and 63/390 (16.2%; 95% CI 13.0-20.4; P < 0.001); RT = 17/81 (21.0%; 95% CI 13.2-30.8; P = 0.002) and 9/81 (11.1%; 95% CI 5.7-19.5; P = 0.001); and control = 36/450 (8.0%; 95% CI 5.8-10.8; P < 0.001) and 18/450 (4%; 95% CI 2.5-6.2; P < 0.001). Adjusted mortality and adjusted combined outcomes in CKD group and HD groups were significantly higher than the control group [hazard ratio (HR) (95% CI) CKD: 2.88 (1.52-5.44); P = 0.00, Turkish Society of Nephrology

Published
2020

36. Periton Diyalizi Başvuru Kitabı Güncellenmiş 2. Baskı

Author

Kazancıoğlu, Rümeyza and KAZANCIOĞLU, Rümeyza

Subjects
Kazancıoğlu R., Gündelik uygulamalar sırasında kullanılabilecek formüller, -Periton Diyalizi Başvuru Kitabı Güncellenmiş 2. Baskı-, Fevzi Ersoy,Taner Çamsarı, Editör, Güneş Tıp Kitabevleri, Ankara, ss.331-332, 2019, Kazancıoğlu R., Periton diyalizinde hasta eğitimi ve periton diyalizi hemşiresinin rolü, -Periton Diyalizi Başvuru Kitabı Güncellenmiş 2. Baskı-, Fevzi Ersoy,Taner Çamsarı, Editör, Güneş Tıp Kitapevleri, Ankara, ss.303-311, 2019, Kazancıoğlu R., Periton Diyalizi Ünitesi Yapısı ve Çalışma Prensipleri, -Periton Diyalizi Başvuru Kitabı Güncellenmiş 2. Baskı-, Fevzi Ersoy,Taner Çamsarı, Editör, Güneş Tıp Kitabevleri, Ankara, ss.311-318, 2019, Kazancıoğlu R., Kateter çıkış tüneli ve kateter çıkış yerinin özellikler, enfeksiyon ve diğer komplikasyonları, -Periton Diyalizi Başvuru Kitabı Güncellenmiş 2. Baskı-, Fevzi Ersoy,Taner Çamsarı, Editör, Güneş Tıp Kitabevleri, Ankara, ss.91-105, 2019
Published
2019

37. Increasing access to integrated ESKD care as part of universal health coverage

Author

Harris, David C. H., DAVIES, Simon J., Finkelstein, Fredric O., JHA, Vivekanand, DONNER, Jo-Ann, ABRAHAM, Georgi, Bello, Aminu K., CASKEY, Fergus J., GARCIA GARCIA, Guillermo, HARDEN, Paul, KAZANCIOĞLU, RÜMEYZA TURAN, Hemmelgarn, Brenda, JOHNSON, David W., LEVIN, Nathan W., Luyckx, Valerie A., MARTIN, Dominique E., McCulloch, Mignon I., MOOSA, Mohammed Rafique, O'Connell, Philip J., Okpechi, Ikechi G., PECOITS FILHO, Roberto, SHAH, Kamal D., SOLA, Laura, Swanepoel, Charles, Tonelli, Marcello, TWAHIR, Ahmed, VAN BIESEN, Wim, VARGHESE, Cherian, Yang, Chih-Wei, ZUNIGA, Carlos, ABU ALFA, Ali K., ALJUBORI, Harith M., ALRUKHAIMI, Mona N., ANDREOLI, Sharon P., ASHUNTANTANG, Gloria, Bellorin-Font, Ezequiel, BERNIEH, Bassam, IBHAIS, Fuad M., BLAKE, Peter G., BROWN, Mark, BROWN, Edwina, BUNNAG, Sakarn, CHAN, Tak Mao, CHEN, Yuqing, CLAURE-DEL GRANADO, Rolando, CLAUS, Stefaan, COLLINS, Allan, COPPO, Rosanna, COUCHOUD, Cecile, CUETO-MANZANO, Alfonso, CULLIS, Brett, DOUTHAT, Walter, DREYER, Gavin, EIAM-ONG, Somchai, EKE, Felicia U., Feehally, John, GHNAIMAT, Mohammad A., LEONG, Bak, HASSAN, Mohamed H., HOU, Fan Fan, JAGER, Kitty, KALANTAR-ZADEH, Kamyar, Levin, Adeera, LIEW, Adrian, McKnight, Marla, TADESSE, Yewondwassesn, Morton, Rachael L., Muller, Elmi, Murtagh, Fliss E. M., Naicker, Saraladevi, Nangaku, Masaomi, NIANG, Abdou, OBRADOR, Gregorio T., OSSAREH, Shahrzad, Perl, Jeffrey, RAHMAN, Muhibur, RASHID, Harun Ur, RICHARDS, Marie, RONDEAU, Eric, SAHAY, Manisha, SALEH, Abdulkarim, SCHNEDITZ, Daniel, TCHOKHONELIDZE, Irma, TESAR, Vladimir, Trask, Michele, TUNGSANGA, Kriang, VACHHARAJANI, Tushar, WALKER, Rachael C., WALKER, Robert, WERE, Anthony J. O., YAO, Qiang, YEATES, Karen, YU, Xueqing, ZAKHAROVA, Elena, ZEMCHENKOV, Alexander, Turan Kazancıoğlu, Rümeyza, Zhao, Ming-Hui, and KAZANCIOĞLU, RÜMEYZA

Abstract

The global nephrology community recognizes the need for a cohesive strategy to address the growing problem of end-stage kidney disease (ESKD). In March 2018, the International Society of Nephrology hosted a summit on integrated ESKD care, including 92 individuals from around the globe with diverse expertise and professional backgrounds. The attendees were from 41 countries, including 16 participants from 11 low- and lower-middle-income countries. The purpose was to develop a strategic plan to improve worldwide access to integrated ESKD care, by identifying and prioritizing key activities across 8 themes: (i) estimates of ESKD burden and treatment coverage, (ii) advocacy, (iii) education and training/workforce, (iv) financing/funding models, (v) ethics, (vi) dialysis, (vii) transplantation, and (viii) conservative care. Action plans with prioritized lists of goals, activities, and key deliverables, and an overarching performance framework were developed for each theme. Examples of these key deliverables include improved data availability, integration of core registry measures and analysis to inform development of health care policy; a framework for advocacy; improved and continued stakeholder engagement; improved workforce training; equitable, efficient, and cost-effective funding models; greater understanding and greater application of ethical principles in practice and policy; definition and application of standards for safe and sustainable dialysis treatment and a set of measurable quality parameters; and integration of dialysis, transplantation, and comprehensive conservative care as ESKD treatment options within the context of overall health priorities. Intended users of the action plans include clinicians, patients and their families, scientists, industry partners, government decision makers, and advocacy organizations. Implementation of this integrated and comprehensive plan is intended to improve quality and access to care and thereby reduce serious health-related suffering of adults and children affected by ESKD worldwide.

Published
2019

40. Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease.

Author

Heybeli, Cihan, Soysal, Pınar, and Kazancıoğlu, Rümeyza

Subjects
CHRONIC kidney failure, OLDER people, CHRONICALLY ill, OLDER patients, MORTALITY, SERUM albumin, VITAMIN D
Abstract

Objective: Studies on predictors of mortality among elderly chronic kidney disease (CKD) patients have conflicting results. We aimed to assess the factors related to mortality in CKD versus non-CKD elderly subjects. Methods: Medical records of consecutive elderly subjects presented to geriatrics outpatient clinics were retrospectively searched. Logistic regression models were set in order to determine independent predictors of mortality. Results: The median age was 73 (67-80) years, and 837 (67.9%) were female. CKD constituted 21.9% of the cohort. During the follow-up of 3 to 4 years, 7.2% of the patients died. In the CKD cohort, older age (per year, OR 1.12, 95% CI 1.01-1.25, P = .040) and serum uric acid levels (per 1 mg/dL increase, OR 1.74, 95% CI 1.12-2.69, P = .013) were associated with a higher risk of mortality while serum albumin (per 1 g/dL increase, OR 0.08, 95% CI 0.01-0.52, P = .008) and vitamin D levels (per 1 ng/mL increase, OR 0.77, 95% CI 0.62-0.96, P = .019) were associated with a lower risk of mortality in the multivariate regression model. Conclusion: Older age, lower serum albumin and vitamin D levels, and higher serum uric acid levels are independent predictors of mortality in outpatient elderly subjects with CKD. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

41. Kanserli hastalarda kemoterapinin böbrek fonksiyonlari üzerine uzun dönem etkisi

Author

Kazancıoğlu, Rümeyza, Gürsu, Meltem, and GÜRSU, Meltem

Subjects
Kazancıoğlu R., Gürsu M., - Kanserli hastalarda kemoterapinin böbrek fonksiyonlari üzerine uzun dönem etkisi.-, . 35. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi , Antalya, Türkiye, 3 - 07 October 2018, ss.21-22
Published
2018

42. Ratlarda Whey protein alimi ve egzersizin kemik mineral metabolizmasina etkisi

Author

Kazancıoğlu, Rümeyza, Gürsu, Meltem, and KAZANCIOĞLU, Rümeyza

Subjects
Kazancıoğlu R., Gürsu M., -Ratlarda Whey protein alimi ve egzersizin kemik mineral metabolizmasina etkisi-, 35. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi , Antalya, Türkiye, 3 - 07 October 2018, ss.12-13
Published
2018

45. Uzun dönem Whey proteini kullanimi ile egzersizin olasi böbrek yan etkileri

Author

Kazancıoğlu, Rümeyza, Gürsu, Meltem, and KAZANCIOĞLU, Rümeyza

Subjects
Kazancıoğlu R., Gürsu M., -Uzun dönem Whey proteini kullanimi ile egzersizin olasi böbrek yan etkileri-, 35. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Türkiye, 3 - 07 October 2018, ss.11
Published
2018

46. Akut piyelonefrite başlı bilateral böbrek büyümesi ve akut böbrek hasarı

Author

Kazancıoğlu, Rümeyza, Gürsu, Meltem, and KAZANCIOĞLU, Rümeyza

Subjects
35. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi , Antalya, Türkiye, 3 - 07 October 2018, ss.166 [Kazancıoğlu R., Gürsu M., -Akut piyelonefrite başlı bilateral böbrek büyümesi ve akut böbrek hasarı]
Published
2018

49. Hipernatremiye bağli korpus kallozum spleniumda diffüzyon kisitlanmasi saptanan olgu

Author

Deligöz Bildacı, Yelda, Gürsu, Meltem, Artan, Ayşe Serra, Elçioğlu, Ömer Celal, Akpınar , Atilla, Kazancıoğlu, Rümeyza, GÜRSU, Meltem, and ELÇİOĞLU, Ömer Celal

Subjects
AKPINAR A., ELÇİOĞLU Ö. C. , DELİGÖZ BİLDACI Y., ARTAN A. S. , GÜRSU M., KAZANCIOĞLU R., -Hipernatremiye Bağli Korpus Kallozum Spleniumda Diffüzyon Kisitlanmasi Saptanan Olgu.-, 35. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Türkiye, 03 Ekim 2018, Akpınar A., Elçioğlu Ö., Deligöz Bildacı Y., Artan A., GÜRSU M., KAZANCIOĞLU R., -Hipernatremiye bağli korpus kallozum spleniumda diffüzyon kisitlanmasi saptanan olgu-, 35. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Türkiye, 07 Ekim 2018
Published
2018

50. Diyabetik Ayak Enfeksiyonu için Kullanılan Tigesikline Bağlı Ciddi Hipoglisemi

Author

Kazancıoğlu, Rümeyza, Gürsu, Meltem, and KAZANCIOĞLU, Rümeyza

Subjects
Kazancıoğlu R., Gürsu M., -. Diyabetik Ayak Enfeksiyonu için Kullanılan Tigesikline Bağlı Ciddi Hipoglisemi-, 35. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Türkiye, 3 - 07 October 2018, ss.164-165, 35. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Türkiye, 3 - 07 October 2018, ss.164-165 [Kazancıoğlu R., Gürsu M., -Diyabetik ayak enfeksiyonu için kullanılan tigesikline bağlı ciddi hipoglisemi]
Published
2018

Catalog

Books, media, physical & digital resources
See catalog results